MYRIAD GENETICS, INC.

Lobbying for MYRIAD GENETICS, INC.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $290,000.00 expenses · posted Jul 21, 2025

Lobbying activity 1

Medicare/Medicaid

Congressional oversight of Medicare Advantage and prior authorization misuses.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem